Poliomyelitis Vaccine (Oral) Bivalent Type 1 and 3 — Vial, 10 dose(s)

PRODUCT OVERVIEW: Poliomyelitis Vaccine (Oral) Bivalent Type 1 and 3 is listed as a polio vaccine - oral bivalent type 1 and 3 product from Serum Institute of India Pvt. Ltd.. It belongs to the vaccine category associated with poliomyelitis. The documented presentation is vial, with 10 dose(s) per container. Oral and inactivated polio vaccines are different products with distinct programme roles. Confirm whether this is OPV, IPV or a particular valency.

WHAT TO CHECK: For safe procurement, request a verified source, batch documentation, expiry date and intact original packaging. Where a patient has questions about allergies, past reactions or medical history, a clinician should assess suitability before administration. Look closely at oral versus inactivated formulation and immunisation programme when comparing this listing with a vaccination record or procurement request. Before proceeding, ask a licensed professional to confirm the intended patient or programme, the current package insert and the appropriate administration setting.

PRACTICAL ORDERING NOTES: Vaccines are temperature-sensitive biological products; dispatch arrangements must be checked against manufacturer instructions and local cold-chain requirements. Product availability, locally approved indications, required prescriptions and any administration fees may differ from the catalogue information. A qualified health professional should confirm vaccination timing and eligibility; this description is not a vaccination schedule.

PROFESSIONAL REVIEW: For Poliomyelitis Vaccine (Oral) Bivalent Type 1 and 3, any decision about use, timing, contraindications and administration rests with an appropriately qualified healthcare practitioner. Ask the supplier to confirm oral versus inactivated formulation and immunisation programme together with the exact labelled presentation. If the vaccine must be transported to a clinical facility, arrange validated temperature-controlled delivery and confirm acceptance conditions with the receiving team. When you are ready to proceed, have the clinician or procurement officer review a current manufacturer package insert and official local regulatory information.